Digital Twins Could Test Medical Treatments for Critically Ill

The University of Vermont’s Larner College of Medicine is spearheading a project to investigate the potential of digital twins in testing medical treatments for critically ill patients. This initiative has secured up to $38 million in funding from the Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department of Health and Human Services. The university announced that this award represents the largest grant in its history. The project, officially named Reprogramming Severe Critical Illness Using Extensible Digital Twins (ReSCUED), will be directed by Dr. Gary An, a trauma surgeon and professor at the University of Vermont. A digital twin is defined as a computational model of a real-world system or object that continuously updates using data to maintain synchronization with its physical counterpart. This allows for insights into how the real entity might respond under various conditions and hypothetical scenarios. The complexities of immune system dysfunction, even with current medical advancements, continue to present significant challenges in critical care. Dr. An highlighted sepsis, a life-threatening condition where the immune system overreacts to an infection, as a prime example of such a challenge. He stated that sepsis is a substantial healthcare problem, expected to grow as the population ages and medical interventions improve survival rates. Dr. An further explained that in intensive care units (ICUs), some patients' bodies struggle to recover from immune dysfunction, and current medical knowledge lacks effective interventions to assist them. This is where the concept of digital twins is intended to provide a solution. The ReSCUED project is projected to span five years. During this period, participant data, including medical records and frequent blood sample analyses, will be utilized to refine computational models that accurately represent an individual's immune responses. The overarching goal is to enable researchers to learn from these digital twins and to "evaluate potential treatment strategies" in a simulated environment before administering them to patients. Participant data collection will be ongoing throughout the project's duration, ensuring the digital twins remain as accurate and up-to-date as possible. The development of these sophisticated digital twins aims to revolutionize how critical care decisions are made, potentially leading to more personalized and effective treatment plans for patients facing severe illnesses.